Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Philippe Masset appointed to Vect-Horus board of directors

April 25, 2025 Research and Development Oncology, Vect-Horus, appointment, board of directors, imaging agents

Vect-Horus has announced the appointment of Philippe Masset to the company’s board of directors. This contributes to a series of …
Appointment
blood_tests_pic

Mursla Bio’s platform for surveillance of liver cancer receives FDA approval

April 24, 2025 Industry Associations, Research and Development BDD, FDA, Mursla Bio, Oncology, hepatocellular carcinoma (HCC), liver disease

The US Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) to EvoLiver, Mursla Bio’s surveillance platform for …
News

Hansa Biopharma appoints Renée Aguiar-Lucander as CEO

April 24, 2025 Research and Development CEO, Corporate, Hansa Biopharma, appointment, immunology

Swedish biopharma company, Hansa Biopharma, has announced the appointment of new chief executive officer (CEO) Renée Aguiar-Lucander, replacing Søren Tulstrup …
Appointment

ViroCell and UCL launch trial to treat childhood leukaemia relapse

April 24, 2025 Research and Development Oncology, UCL, ViroCell, acute lymphoblastic leukaemia, cell therapy, clinical trial, leukaemia

ViroCell Biologics has manufactured a GMP-grade lentiviral vector for a University College London (UCL) clinical trial aimed at tackling relapse …
News

Dual immunotherapy for bowel cancer now available under NHS

April 23, 2025 Research and Development Bristol Myer Squibb, MHRA, NICE, Oncology, bowel cancer, colorectal cancer, immunotherapy

Dual immunotherapy, a combination of Opdivo (nivolumab) and Yervoy (ipilimumab), has been granted extension in the UK by the Medicines …
News
handshake_2

AOTI diabetic foot care therapy to be used by NHS

April 23, 2025 Research and Development AOTI, Diabetes, diabetes, diabetic foot care, health economic study

Effective from September 2025, AOTI’s Topical Wound Oxygen (TWO2) therapy has been awarded inclusion in the NHS supply chain. It …
News

Galapagos announces leadership changes amid planned company split

April 22, 2025 Analytical & Laboratory Services, Research and Development CEO Appointment, Corporate, Galapagos, cell therapy

Galapagos NV has announced key leadership changes as it prepares to separate into two independent entities. Henry Gosebruch has been …
Appointment

Allegro confirms successful safety testing of osteoarthritis treatment

April 17, 2025 Research and Development Allegro, Osteoporosis, joint disease, oesteoarthritis, pretrial

Allegro’s hydrocelin treatment for osteoarthritis has demonstrated a satisfactory safety profile, giving it potential to become a leading disease-modifying treatment …
News
blood_test

Johnson & Johnson announces successful results from trial for myeloma treatment

April 16, 2025 Research and Development Johnson & Johnson, Oncology, myeloma, pharma, trial

Global healthcare company, Johnson & Johnson, announced that analysis of its Darzalex (daratumumab) therapy showed significantly longer progression-free survival (PFS) …
News

ProQR appoints new CFO and CMO to drive clinical-stage growth

April 15, 2025 Research and Development Corporate, ProQR, appointments, clinical development

ProQR Therapeutics announced two major leadership appointments to support its transition into the clinical development phase of its RNA editing …
Appointment

Successful trial results announced for potential rare eye disease treatment

April 14, 2025 Research and Development Eyestem, Opthalmology, age-related macular degeneration (AMD), biotech, cell therapy, eye disease

Eyestem Research, an Indian biotech company, announced successful results from its phase 1 trial of Eyecyte-RPE, a potential therapy for …
News

Nordic Pharma’s Lacrifill canalicular gel gains CE mark approval and set for European launch

April 14, 2025 Market Access, Research and Development, Sales and Marketing Nordic Pharma, Opthalmology, dry eye disease

International pharma company Nordic Pharma has announced that its Lacrifill treatment for dry eye disease has received European Conformity (CE) …
News
blood-1813410_960_720

First cohort dosed with potential treatment for Von Willebrand disease

April 11, 2025 Research and Development Haematology, Hemab Therapeutics, Richmond Pharma, Von Willebrand Disease, bleeding disorder

UK-based clinical trials company, Richmond Pharmacology, has completed the first stage of Velora Pioneer, a phase 1/2 clinical trial investigating …
News

Inbiome’s rapid diagnostic platform approved for EU use, cuts infection identification time to just five hours

April 11, 2025 Research and Development Diagnostics, EU, Inbiome

Dutch diagnostics firm Inbiome has received In Vitro Diagnostic Regulation (IVDR) certification from the EU for its Molecular Culture ID …
News

AAX Biotech aims to enhance growth with two new appointments

April 10, 2025 Business Development, Recruitment, Research and Development AAX Biotech, Immunology, Oncology, R&D development, antibody therapeutics, business development

AAX Biotech has appointed Ionut Gabriel Dumitru (pictured left) as senior scientist and Kushal Sejwal (pictured right) as business developer, …
Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025